DRD2 and diabetes mellitus: Although diabetic mice remained hyperglycemic throughout the experiment (Supporting Fig. 5), these results show for the first time that interference with dopamine signaling in diabetes can restore normal bone health, pointing to D2R signaling inhibitors as providing new potential therapeutic strategies for diabetic bone disease.